Octapharma

This Phase 3 study tested whether Panzyga (an intravenous immunoglobulin treatment) works better than a placebo for children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS). The trial involved 71 children and teenagers aged 6-17 who suddenly developed severe ob…

This study tested a drug called Wilate to see if it could safely prevent bleeding episodes in very young children with a severe form of von Willebrand disease (VWD), a rare bleeding disorder. Twelve children under 6 years old received regular doses of Wilate for a year to see how…

This study tested whether regular infusions of Panzyga (an antibody product) could prevent serious infections in adults with chronic lymphocytic leukemia (CLL) who have low antibody levels. 247 participants were randomly assigned to receive either Panzyga or a placebo infusion ev…